Dealings in securities by a director of a major subsidiary
DISCOVERY LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 1999/007789/06)
Legal Entity Identifier: 378900245A26169C8132
JSE share code: DSY, DSYBP
DSY ISIN: ZAE000022331
DSBP ISIN: ZAE000158564
Bond company code: DSYI
("Discovery")
DEALINGS IN SECURITIES BY A DIRECTOR OF A MAJOR SUBSIDIARY
In compliance with the JSE Limited Listings Requirements and Debt Listings Requirements, the following
information is disclosed.
Shareholders and noteholders are advised of the following dealings by a director of Discovery Health
Proprietary Limited, a major subsidiary of Discovery.
Name : Dr Jonathan Broomberg
Company : Discovery Health Proprietary Limited
Office held : Non-executive Director
Nature of transaction : On-market purchase of securities
Class of securities : Ordinary shares
Nature of interest : Direct beneficial
Clearance obtained : Yes
Date of transaction : 9 September 2022
Number of shares : 8,889
Volume weighted average purchase price : R111.0790 per share
Highest traded price : R111.6800 per share
Lowest traded price : R110.2300 per share
Total value of transaction : R987,381.23
Sandton
15 September 2022
Sponsor and Debt Sponsor
RAND MERCHANT BANK (A division of FirstRand Bank Limited)
Date: 15-09-2022 04:50:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.